CtrlK
ADMA Biologics
ADMA90
$17.91arrow_drop_down3.13%-$0.57
High Quality
High Growth
ADMA90
$17.91
arrow_drop_down3.13%Performance History
There's no data available for performance history chart
| Key Stats | |
|---|---|
| Open | $18.52 |
| Prev. Close | $18.50 |
| EPS | 0.27 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $4.23B |
| PE Ratio | 66.33 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 17.64 | 19.25 |
| 52 Week Range | 3.06 | 23.53 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
There's no data available for Analyst Forecast
Period: -
• Predicted: -Analyst Ratings
There's no data available for Analyst Ratings
Last updated: -
• Total: -About ADMA Biologics (ADMA)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Adam S. Grossman
- Headquarters
- Ramsey
- Employees
- 617
- Exchange
- NASDAQ
Keep an eye on ADMA Biologics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is ADMA Biologics 's (ADMA) price per share?
The current price per share for ADMA Biologics (ADMA) is $17.91. The stock has seen a price change of -$0.58 recently, indicating a -3.14% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for ADMA Biologics (ADMA)?
For ADMA Biologics (ADMA), the 52-week high is $23.53, which is 31.4% from the current price. The 52-week low is $3.06, the current price is 485.29% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is ADMA Biologics (ADMA) a growth stock?
ADMA Biologics (ADMA) has shown an average price growth of -1.65% over the past three years. It has received a score of 94 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying ADMA Biologics as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is ADMA Biologics (ADMA) stock price performance year to date (YTD)?
As of the latest data, ADMA Biologics (ADMA) has a year-to-date price change of 4.43%. Over the past month, the stock has experienced a price change of 11.38%. Over the last three months, the change has been -3.66%. Over the past six months, the figure is -1%. Looking at a longer horizon, the five-year price change stands at 729.17%.
help
Is ADMA Biologics (ADMA) a profitable company?
ADMA Biologics (ADMA) has a net income of -$28.24M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 34.44% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 33.08% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $258.21M, with a revenue growth rate of 67.59%, providing insight into the company's sales performance and growth. The gross profit is $88.94M. Operating income is noted at $21.63M. Furthermore, the EBITDA is $125.01M.
help
What is the market capitalization of ADMA Biologics (ADMA)?
ADMA Biologics (ADMA) has a market capitalization of $4.24B. The average daily trading volume is 17.96, indicating the stock's liquidity and investor engagement.